Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PC Chemotherapy in Recurrent Glioblastoma
NCT01737346Phase 2Unknown
- Sponsor
- Incheon St. Mary's Hospital
- Start
- Oct 2012
- Primary completion
- Sep 2013
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of lomustine, procarbazine in glioblastoma (GBM), sponsored by Incheon St. Mary's Hospital. Status: unknown.
02
Drugs
lomustineprocarbazine
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT01737346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01737346.